Stockreport

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Data demonstrate that the Omicron KP.2-adapted COVID-19 vaccine generates a substantially improved response against multiple circulating Omicron JN.1 sublineages as did [Read more]